520 participants
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2026-10-20
- Completion:
- 2028-07-01
Conditions
- Atopic Dermatitis
Interventions
- DRUG
No Results Yet